Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Briel

Showing results (231-240 of 288) with videos related to

Pageof 29
Sort By:
Trials|June 13, 2009
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impactElie A Akl, Matthias Briel, John J You, et al.
Trials|January 9, 2020
Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is neededShaun Treweek, Simon Bevan, Peter Bower, et al.
BMJ (Clinical Research Ed.)|August 12, 2018
Corticosteroid therapy for sepsis: a clinical practice guidelineFrancois Lamontagne, Bram Rochwerg, Lyubov Lytvyn, et al.
Expert Review of Anti-Infective Therapy|July 4, 2018
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trialsPhilipp Schuetz, Rebekka Bolliger, Meret Merker, et al.
BMJ (Clinical Research Ed.)|March 17, 2012
Credibility of claims of subgroup effects in randomised controlled trials: systematic reviewXin Sun, Matthias Briel, Jason W Busse, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspectivePhilipp Schuetz, Robert Balk, Matthias Briel, et al.
Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.
BMJ (Clinical Research Ed.)|February 18, 2009
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysisMatthias Briel, Ignacio Ferreira-Gonzalez, John J You, et al.
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
Trials|August 23, 2020
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative studyBenjamin Kasenda, Junhao Liu, Yu Jiang, et al.
Pageof 29

Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
Trials|June 13, 2009
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impactElie A Akl, Matthias Briel, John J You, et al.
Trials|January 9, 2020
Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is neededShaun Treweek, Simon Bevan, Peter Bower, et al.
BMJ (Clinical Research Ed.)|August 12, 2018
Corticosteroid therapy for sepsis: a clinical practice guidelineFrancois Lamontagne, Bram Rochwerg, Lyubov Lytvyn, et al.
Expert Review of Anti-Infective Therapy|July 4, 2018
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trialsPhilipp Schuetz, Rebekka Bolliger, Meret Merker, et al.
BMJ (Clinical Research Ed.)|March 17, 2012
Credibility of claims of subgroup effects in randomised controlled trials: systematic reviewXin Sun, Matthias Briel, Jason W Busse, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspectivePhilipp Schuetz, Robert Balk, Matthias Briel, et al.
Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.
BMJ (Clinical Research Ed.)|February 18, 2009
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysisMatthias Briel, Ignacio Ferreira-Gonzalez, John J You, et al.
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
Trials|August 23, 2020
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative studyBenjamin Kasenda, Junhao Liu, Yu Jiang, et al.
Pageof 29